Top Ten most popular articles on Pharmafile.com this week
May 19, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten
With every week we draw closer to the event everyone in the UK is talking about – the general election. …
J&J launches lawsuit to block release of Remicade biosimilar
May 19, 2017Medical Communications, Sales and Marketing J&J, JJ, Remicade, Samsung Bioepis
Samsung Bioepis gained approval to launch its biosimilar to Johnson & Johnson’s Remicade just last month, on 21 April, but …
Pharma’s Identity Crisis: Four strategies for creating value in life sciences
May 19, 2017Medical Communications pharmafile
As the demands of healthcare across the world begin to rise, PwC outlines four strategies for creating value in life …
Dr Reddy’s gets greenlight to market Doxil generic
May 18, 2017Sales and Marketing Dr Reddy's, FDA
Dr Reddy’s Laboratories, one of India’s largest pharmaceutical firms, has revealed that the FDA has given the go-ahead to market …
Off-patent cancer drug holds promise for severe asthma treatment
May 18, 2017Research and Development asthma, imatinib
Researchers from Brigham and Women’s Hospital and Harvard Medical School have conducted a small-scale study into the prospect of using …
FDA approves first ALS/Lou Gehrig’s disease therapy in 22 years
May 18, 2017Research and Development, Sales and Marketing Mitsubishi Tanabe Pharma, als
The FDA has announced that it has approved Mitsubishi Tanabe Pharma’s Radicava (edaravone) for the treatment of amyotrophic lateral sclerosis(ALS), …
Research suggests opioid crisis stems from prescription approach
May 18, 2017Medical Communications, Research and Development opioid crisis, opioids
The opioid crisis that is currently gripping North America is gaining more and more news traction as the damage to …
500 staff face the axe as Teva cans Hungary plant
May 18, 2017Manufacturing and Production Teva
Israeli pharmaceutical firm Teva has announced that it plans to cease operations at a manufacturing plant in Gödöllő in Budapest, …
AZ launches lawsuit against former executive for defecting to GSK
May 17, 2017Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline
AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …
Bayer celebrates FDA priority review for investigational blood cancer drug
May 17, 2017Research and Development, Sales and Marketing Bayer, FDA, blood cancer
Bayer has announced that its investigational blood cancer treatment copanlisib has been awarded priority review designation from the FDA, meaning …
T cells found to ‘acquire knowledge’ to take fight to metastatic cancer
May 17, 2017Research and Development Cancer, T cell, immunotherapy
T cells are widely known as being crucial in the fight against cancer within the body but little was known, …
FDA demands new warnings for J&J diabetes drug over amputation risk
May 17, 2017Manufacturing and Production, Research and Development, Sales and Marketing J&J, JJ, Johnson & Johnson, diabetes
Johnson & Johnson has found itself in deep water again over the potentially harmful effects of its products. This time …
Sangamo secures FDA’s Fast Track Designation for haemophilia candidate
May 17, 2017Research and Development, Sales and Marketing FDA, Pfizer, Sangamo Therapeutics
Sangamo Therapeutics has announced that the FDA has granted its cDNA gene therapy candidate for haemophilia A Fast Track Designation. …
Common treatment for MS revealed to have potential adverse reactions
May 16, 2017Manufacturing and Production, Research and Development MS, multiple sclerosis
Beta interferons are a common treatment used to manage multiple sclerosis. The treatment works by reducing and preventing the inflammation …
New FDA Commissioner Gottlieb restructures workforce with product-based focus areas
May 16, 2017Manufacturing and Production, Sales and Marketing FDA, Scott Gottlieb
Scott Gottlieb has wasted no time since his appointment to the role of FDA Commissioner last week. As one of …
European Commission targets Aspen over 1,500% price hikes
May 16, 2017Manufacturing and Production, Sales and Marketing European Commission, aspen
The European Commission (EC) has opened its first investigation over drug pricing following alleged hiking by pharma company Aspen, which …
Patient death sparks safety worries in Ionis trial
May 16, 2017Manufacturing and Production, Research and Development Ionis Pharmaceuticals
Ionis Pharmaceuticals announced the results from a Phase 3 trial of its drug to treat patients with familial amyloid polyneuropathy …
Cuba looks to begin trials of new neuroprotective treatment for Alzheimer’s
May 16, 2017Manufacturing and Production, Research and Development Alzheimer's, Cuba, dementia
The health care system in Cuba is widely held up to be a model of innovation; despite severe economic sanctions …
GSK mulls $8 billion healthcare consolidation deal
May 15, 2017Sales and Marketing GSK, Novartis
When GSK and Novartis first agreed their business swap and healthcare joint venture, it was seen as marking a shift …
Brain drain: The experts the UK may lose due to Brexit
May 15, 2017Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing brexit
The regulatory and drug approval process is destined to change once the UK leaves the EU. The problem is, nobody …
